Get Level 2

Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. MaxCyte Share Price
  4. MaxCyte Share Regulatory News

Pin to quick picksMaxCyte Regulatory News (MXCT)

MaxCyte Information
  • There is currently no data for MXCT
12345678910
Date   Source Headline
4th Jan 20237:00 amRNSSigning of Strategic Platform License
5th Dec 20227:00 amRNSSigning of Strategic Platform License
2nd Dec 20225:22 pmRNSTotal Voting Rights
1st Dec 20227:00 amRNSNon-Executive Director Appointment
11th Nov 20227:00 amRNSHolding(s) in Company
10th Nov 20227:01 amRNSFiling of Form 10-Q
10th Nov 20227:00 amRNSMaxCyte Reports Third Quarter Financial Results
2nd Nov 202212:05 pmRNSParticipation in Upcoming Investor Conferences
1st Nov 20229:25 amRNSTotal Voting Rights
17th Oct 20222:58 pmRNSHolding(s) in Company
12th Oct 20221:00 pmRNSNotice of Third Quarter 2022 Financial Results
3rd Oct 20229:42 amRNSTotal Voting Rights and Block Listing Return
28th Sep 20221:05 pmRNSSigning of Strategic Platform License
21st Sep 20221:05 pmRNSNew Maryland headquarters
8th Sep 20227:00 amRNSMorgan Stanley Healthcare Conference Participation
1st Sep 20224:39 pmRNSTotal Voting Rights
11th Aug 20227:00 amRNSFiling of Form 10-Q for Second Quarter
11th Aug 20227:00 amRNSSecond Quarter and Half-Year Results
2nd Aug 20222:44 pmRNSTotal Voting Rights
20th Jul 202210:00 amRNSChange of Registered Office
15th Jul 20221:01 pmRNSNotice of Results
12th Jul 20221:01 pmRNSSigning of Strategic Platform License
12th Jul 20227:00 amRNSGrant of Options
8th Jul 20225:16 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
30th Jun 20227:00 amRNSResult of AGM
17th Jun 20222:51 pmRNSHoldings in Company
6th Jun 20227:00 amRNSPublication of Annual Report
27th May 20227:00 amRNSNotice of AGM
16th May 20227:00 amRNSInducement Grants
10th May 20227:00 amRNSFiling of Form 10-Q
10th May 20227:00 amRNSMaxCyte Reports First Quarter Financial Results
4th May 20227:00 amRNSUpcoming Investor Conferences
29th Apr 20222:41 pmRNSTotal Voting Rights
19th Apr 20227:00 amRNSInducement Grants Under Nasdaq Listing Rule 5635
13th Apr 20227:00 amRNSDeparture of CFO and Preliminary Q1 2022 Revenue
11th Apr 20227:00 amRNSHolding(s) in Company
1st Apr 20227:02 amRNSTotal Voting Rights
28th Mar 20221:19 pmRNSGrant of Options and PDMR Dealing
28th Mar 20227:00 amRNSGrant of Options and PDMR Dealing
23rd Mar 20227:00 amRNSFourth Quarter and Full Year Financial Results
10th Mar 20227:00 amRNSMaxCyte, Names Cenk Sumen Chief Scientific Officer
8th Mar 20222:29 pmRNSHolding(s) in Company
3rd Mar 20229:45 amRNSHolding(s) in Company
1st Mar 20227:00 amRNSBlock Listing Return
24th Feb 20221:00 pmRNSNotice of Results
22nd Feb 20223:56 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSConsolidation of Trading Lines
14th Feb 20221:00 pmRNSUpcoming Investor Conferences
14th Feb 20227:00 amRNSInducement Grants Under Nasdaq Listing Rule
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
DIVI
Diverse Income Trust
LSE
0.00%
W7L
Warpaint London
LSE
-0.24%
MIRA
MIRA.L
LSE
0.00%
LIKE
Likewise Group
LSE
-1.61%
IVPB
IVPB.L
LSE
0.00%
Trending
KOD
Kodal Minerals
LSE
-1.67%
TRP
Tower Resources
LSE
5.56%
ITM
Itm Power
LSE
-3.40%
IMM
Immupharma
LSE
-2.44%
THG
Thg
LSE
-2.33%